Provides cloud software, data, and consulting for life sciences companies, including pharmaceutical and biotechnology businesses.
10-K for FY2026, filed Mar 20, 2026Our industry cloud solutions for the life sciences industry are grouped into four major product categories—Veeva Development Cloud, Veeva…View ↗
Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all…View ↗
Veeva Quality Cloud unifies quality applications, processes, and partners across content management, training, quality assurance, and…View ↗
Veeva Commercial Cloud is a product category comprised of software and analytics solutions built specifically for life sciences companies…View ↗
Veeva Data Cloud is a modern data platform comprised of connected reference data, deep data, and transaction data. The platform is designed…View ↗
We offer Veeva Business Consulting services through dedicated teams that are distinct from our professional services and support…View ↗
Customers pay subscription fees for access to cloud software and data, generally billed at the start of annual or quarterly subscription periods; they also pay for implementation, configuration, managed services, and consulting.
10-K for FY2026, filed Mar 20, 2026We derive our revenues primarily from subscription fees and professional services fees. Subscription revenues consist of fees from…View ↗
Our subscription orders are generally billed at the beginning of the subscription period in annual or quarterly increments, which means the…View ↗
We offer Veeva Business Consulting services through dedicated teams that are distinct from our professional services and support…View ↗
10-K for FY2026, filed Mar 20, 2026
FY2026 revenue by product or service ↗$3.2B
10-K for FY2026, filed Mar 20, 2026
$3.2B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Commercial Solutions
Recurring
10-K for FY2026, filed Mar 20, 2026 |
39%
FY2023: 44%
|
Commercial Solutions, FY2026
$1.3B Sources
|
Recurring |
|
R&D and Quality Solutions
Recurring
10-K for FY2026, filed Mar 20, 2026 |
45% |
R&D and Quality Solutions, FY2026
$1.4B Sources
|
Recurring |
|
Commercial Solutions
|
5.9%
FY2023: 8.2%
|
Commercial Solutions, FY2026
$189.3M Sources
|
|
|
R&D and Quality Solutions
|
10% |
R&D and Quality Solutions, FY2026
$321.8M Sources
|
Sells directly to life sciences companies, including pharmaceutical, biotechnology, medical-device, contract sales, and contract research organizations, and to consumer-products companies.
10-K for FY2026, filed Mar 20, 2026
Yes. It kept 28 cents of every revenue dollar as net income in FY2026.
10-K for FY2026, filed Mar 20, 2026
10-Q for Q2 FY2027, filed Aug 27, 2026
$273.4MView ↗
10-Q for Q2 FY2027, filed Aug 27, 2026
Open tableView ↗
8-K, filed Aug 26, 2026
Total revenues between $932 and $935 million. Non-GAAP operating income between $417 and $420 million.(2) Non-GAAP fully diluted net income…View ↗
Growing. Revenue grew 73% in 4 years, from $1.9B in FY2022 to $3.2B in FY2026, about 15% a year.
Quality software reaches lab work
The older report described quality tools for content, processes, and training; the latest also describes quality-control lab applications for batch testing, stability studies, and environmental monitoring.
10-K for FY2023, filed Mar 30, 2023 10-K for FY2026, filed Mar 20, 2026Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. The platform is designed…View ↗
Veeva Quality Cloud unifies quality applications, processes, and partners across content management, training, quality assurance, and…View ↗
Competes with Salesforce, IQVIA, Ipsos Group, Definitive Health, Dassault Systèmes, OpenText, Oracle, Honeywell, Microsoft, Box, Amazon Web Services, and EtQ Management Consultants
10-K for FY2026, filed Mar 20, 2026The markets for our solutions are global, rapidly evolving, highly competitive, and subject to changing regulations, advancing technology…View ↗
Loading...